Cytek Biosciences Stock (NASDAQ: CTKB) stock price, news, charts, stock research, profile.
Open | $5.880 |
Close | $5.920 |
Volume / Avg. | 421.927K / 706.047K |
Day Range | 5.750 - 5.995 |
52 Wk Range | 3.800 - 12.310 |
Market Cap | $765.321M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 33 |
Short Interest | 8.65% |
Days to Cover | 13.35 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Cytek Biosciences (NASDAQ: CTKB) through any online brokerage.
Other companies in Cytek Biosciences’s space includes: 10x Genomics (NASDAQ:TXG), Codexis (NASDAQ:CDXS), BioLife Solns (NASDAQ:BLFS), Lifecore Biomedical (NASDAQ:LFCR) and Sotera Health (NASDAQ:SHC).
The latest price target for Cytek Biosciences (NASDAQ: CTKB) was reported by Piper Sandler on Wednesday, March 6, 2024. The analyst firm set a price target for 10.00 expecting CTKB to rise to within 12 months (a possible 70.94% upside). 9 analyst firms have reported ratings in the last year.
The stock price for Cytek Biosciences (NASDAQ: CTKB) is $5.85 last updated April 19, 2024 at 5:07 PM EDT.
There are no upcoming dividends for Cytek Biosciences.
Cytek Biosciences’s Q1 earnings are confirmed for Tuesday, May 7, 2024.
There is no upcoming split for Cytek Biosciences.
Cytek Biosciences is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.